Nathalie Goemans

Management Committee Member

Nathalie Goemans, M.D., PhD, is a pediatrician and child neurologist, with certification in rehabilitation medicine , clinical chair of child neurology at the University Hospitals Leuven (Belgium), head of the neuromuscular reference center for children at the UH Leuven and consultant in neuropediatrics at DVC St Jozef Antwerp, Belgium, a rehabilitation centre with residential setting for neuromuscular patients. She is responsible for the traineeship in motor rehabilitation within the department of pediatrics. She is coordinating a multidisciplinary group of experts in the field of paediatric neuromuscular disorders and has experience in clinical research and pharmacological trials in neuromuscular disorders (CINRG trials (Glutamine/Creatinine, Oxatomide), antisense oligonucleotide mediated exon skipping trials (PRO 51/Drisapersen, PRO 44 , PRO 45, PRO 53 (Prosensa Ther.), PTC 124/Ataluren, Idebenone ( Santhera Pharm) and Tadalafil ( Eli Lilly) in Duchenne Muscular Dystrophy and Olesoxime (TROPHOS) in SMA).

She is actively involved in national and international research networks, partner of FP7 and COST projects, with a particular interest in the multidisciplinary aspects and the dissemination of standards of care, ethical issues, outcome measures and transition to adulthood, as well as in the design and conduct of clinical trials in neuromuscular disorders. She defended a doctoral thesis on therapy development and clinical outcome measures for Duchenne muscular dystrophy at the University of Leuven. She is a reviewer for national and international funding organisations (ABMM, NEMA,AFM, TELETHON ITALY, Duchenne Parent Project, Zon MW, AERES) and for pediatric (child)neurology and neuromuscular journals. She has joined the editorial board of Neuromuscular Disorders and Journal of Neuromuscular Diseases.